Bioinvent International Ab

This is an early-stage trial testing a new drug called BI-1808 for people with advanced cancers that have stopped responding to standard treatments. The main goals are to find a safe dose and see how well the body tolerates the drug, both by itself and when combined with an exist…

This study is testing a new drug, BI-1206, given alongside the immunotherapy pembrolizumab. It aims to see if this combination is safe and can help control advanced solid tumors, particularly in adults with non-small cell lung cancer or uveal melanoma who have not responded well …